Did you know that August is National Immunization Awareness Month in the U.S.? No? Well, you could be forgiven if it’s passed you by this year. Because few public bodies “stateside” are shouting about it. The Centers for Disease Control and Prevention (CDC) issued a short item about it on its website last year – […]
It’s August and many of Optimum’s clients are – quite rightly – on the beach. But the world of biopharma does not stop just because it’s the holiday season. Notable developments included moves by the Trump administration to get Europe to pay more for medicines, while he also ramped up the pressure on pharma tariffs. […]
Resilience has become something of a buzzword in recent years – a cliché, even. The regular peaks and troughs that the biotech industry experiences lead many to prescribe ‘resilience’ as a cure-all for tough times. Being resilient is easier said than done when investors don’t seem interested, when politics are so unstable, when you hear […]
Novo Holdings participates in $372.5 million Series D financing of MapLight Therapeutics to advance differentiated CNS therapies Novo Holdings announced its participation in a $372.5 million Series D financing of MapLight Therapeutics, a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system (CNS) disorders. The funds will support […]
Reports of a long-awaited ‘biotech spring’ have been sadly wide of the mark for a couple of years now. But as we roll into sultry August, could things actually be on the verge of blooming? Over the last few months, excited despatches have been landing thick and fast about the Chinese biotech boom, with the […]
